NCT03943771

Brief Summary

Investigators aimed to estimate the effect of showing and handling a three-dimensional modelization of a patient's kidney presenting with tumor the day before his nephron-sparing surgery. The main outcome measure was the effect on anxiety assessed via the STAI score. 2 types kidney models (virtual and printed) will be evaluated as compared to usual information, using a randomization.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 9, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

January 27, 2020

Status Verified

January 1, 2020

Enrollment Period

9 months

First QC Date

May 7, 2019

Last Update Submit

January 22, 2020

Conditions

Keywords

Kidney NeoplasmsCarcinoma, Renal CellNephron-Sparing Surgery3D Modeling3D PrintingAnxietyPersonalized Medicine

Outcome Measures

Primary Outcomes (2)

  • State-anxiety score of the State-Trait Anxiety Inventory (STAI) questionnaire

    Min : 20 = few anxiety Max : 80 = severe anxiety

    The day before renal surgery, up to 1 month after inclusion

  • Visual Analog Scale (VAS) score for anxiety

    Min : 0 = no anxiety Max : 10 = maximum anxiety

    The day before renal surgery, up to 1 month after inclusion

Secondary Outcomes (3)

  • Renal anatomy and surgical strategies questionnaire score

    The day before renal surgery, up to 1 month after inclusion

  • Anxiolytics prescription before surgery

    The day before renal surgery, up to 1 month after inclusion

  • Pain numeric scale score

    The day after renal surgery, up to 1 month after inclusion

Study Arms (3)

Virtual modelization group

EXPERIMENTAL

Patients having their kidney modelized in three dimensions on a software

Other: Anxiety, renal anatomy and surgery questionnaires

Printed modelization group

EXPERIMENTAL

Patients having their kidney modelized and printed in three dimensions

Other: Anxiety, renal anatomy and surgery questionnaires

Control group

SHAM COMPARATOR

No kidney model

Other: Anxiety, renal anatomy and surgery questionnaires

Interventions

The day before surgery, all the patients will be visited by a member of the investigator team for preoperative consultation and will be given a questionnaire evaluating their anxiety based on STAI and VAS scores. The two experimental groups will be offered their renal modelization to be manipulated (virtually or physically) before the questionnaire. A second survey assessing basic renal anatomy and surgery understanding will also be completed by the patients. Anxiolytics prescription prior to surgery will be collected inside the medical file.

Control groupPrinted modelization groupVirtual modelization group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive patients presenting with renal tumor allowing a nephron-sparing surgery
  • Participating in UroCCR database
  • Having a contrast abdominal scanner prior to surgery
  • Owing social insurance contract
  • Inpatient surgery

You may not qualify if:

  • Unable to give informed consent
  • No contrast scanner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Bordeaux

Bordeaux, 33076, France

Location

MeSH Terms

Conditions

Kidney NeoplasmsCarcinoma, Renal CellAnxiety Disorders

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeMental Disorders
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2019

First Posted

May 9, 2019

Study Start

July 1, 2019

Primary Completion

April 1, 2020

Study Completion

April 1, 2020

Last Updated

January 27, 2020

Record last verified: 2020-01

Locations